{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:55Z","timestamp":1793327455698,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T00:00:00Z","timestamp":1754179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005869","name":"Universit\u00e9 de Fribourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008213","name":"South Dakota State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["CRSK-3_221109"],"award-info":[{"award-number":["CRSK-3_221109"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00719","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:46:47Z","timestamp":1755622007000},"page":"e00719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cyanide overproduction impairs cellular bioenergetics in Down syndrome"],"prefix":"10.1016","volume":"22","author":[{"given":"Maria","family":"Petrosino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Zuhra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kieronska-Rudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Janickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Logue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.neurot.2025.e00719_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102416","article-title":"Role of the cystathionine beta-synthase\/H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in Down syndrome","volume":"55","author":"Panagaki","year":"2022","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s10020-020-00225-8","article-title":"Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome","volume":"26","author":"Pecze","year":"2020","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00719_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10863-008-9166-6","article-title":"The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance","volume":"40","author":"Cooper","year":"2008","journal-title":"J Bioenerg Biomembr"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00719_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/1097-4547(20000901)61:5<570::AID-JNR12>3.0.CO;2-V","article-title":"Endogenous generation of cyanide in neuronal tissue: involvement of a peroxidase system","volume":"61","author":"Gunasekar","year":"2000","journal-title":"J Neurosci Res"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00719_bib6","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/febs.16135","article-title":"The two faces of cyanide: an environmental toxin and a potential novel mammalian gasotransmitter","volume":"289","author":"Zuhra","year":"2022","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00719_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s42255-025-01225-w","article-title":"Regulation of mammalian cellular metabolism by endogenous cyanide production","volume":"7","author":"Zuhra","year":"2025","journal-title":"Nat Metab"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00719_bib8","article-title":"Physiological concentrations of cyanide stimulate mitochondrial complex IV and enhance cellular bioenergetics","volume":"118","author":"Randi","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2011.08.005","article-title":"Cyanide preconditioning protects brain endothelial and NT2 neuron-like cells against glucotoxicity: role of mitochondrial reactive oxygen species and HIF-1\u03b1","volume":"45","author":"Correia","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib10","article-title":"Role of cystathionine-beta-synthase and hydrogen sulfide in Down syndrome","volume":"22","author":"Szabo","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00719_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102233","article-title":"Overproduction of hydrogen sulfide, generated by cystathionine \u03b2-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of Down syndrome","volume":"51","author":"Panagaki","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00719_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122385","article-title":"Cyanobiphenyl-spiropyrane and -hemicyanine conjugates for cyanide detection in organic\/aqueous media through reverse ICT direction: their practical applications","volume":"231","author":"Erdemir","year":"2021","journal-title":"Talanta"},{"issue":"27","key":"10.1016\/j.neurot.2025.e00719_bib13","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","article-title":"Lysosomal dysfunction in Down syndrome is APP-dependent and mediated by APP-\u03b2CTF (C99)","volume":"39","author":"Jiang","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00719_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.867989","article-title":"Down syndrome fetal fibroblasts display alterations of endosomal trafficking possibly due to SYNJ1 overexpression","volume":"13","author":"De Rosa","year":"2022","journal-title":"Front Genet"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00719_bib15","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00719_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0006-8993(97)00659-8","article-title":"Hydrogen cyanide generation by \u03bc-opiate receptor activation: possible neuromodulatory role of endogenous cyanide","volume":"768","author":"Borowitz","year":"1997","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neures.2004.01.006","article-title":"Receptor mechanisms mediating cyanide generation in PC12 cells and rat brain","volume":"49","author":"Gunasekar","year":"2004","journal-title":"Neurosci Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00719_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15216540600981768","article-title":"Is there evidence that cyanide can act as a neuromodulator?","volume":"59","author":"Cipollone","year":"2007","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00719_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1099-0461(1999)13:5<253::AID-JBT5>3.0.CO;2-Z","article-title":"Cyanide interaction with redox modulatory sites enhances NMDA receptor responses","volume":"13","author":"Sun","year":"1999","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00719_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/519248","article-title":"Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance","volume":"81","author":"Prandini","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00719_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance","volume":"18","author":"Antonarakis","year":"2017","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.neurot.2025.e00719_bib22","first-page":"1","article-title":"Genetic and epigenetic pathways in Down syndrome: insights to the brain and immune system from humans and mouse models","volume":"251","author":"Yu","year":"2020","journal-title":"Prog Brain Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00719_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad048","article-title":"Polysulfide metabolizing enzymes influence SqrR-mediated sulfide-induced transcription by impacting intracellular polysulfide dynamics","volume":"2","author":"Shimizu","year":"2023","journal-title":"PNAS Nexus"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40635-020-0296-4","article-title":"Emerging pharmacological tools to control hydrogen sulfide signaling in critical illness","volume":"8","author":"Marutani","year":"2020","journal-title":"Intensive Care Med Exp"},{"issue":"38","key":"10.1016\/j.neurot.2025.e00719_bib25","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.1911895116","article-title":"Overproduction of H2S, generated by CBS, inhibits mitochondrial complex IV and suppresses oxidative phosphorylation in Down syndrome","volume":"116","author":"Panagaki","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2017.10.001","article-title":"Dysfunction of autophagy and endosomal-lysosomal pathways: roles in pathogenesis of Down syndrome and Alzheimer's disease","volume":"114","author":"Colacurcio","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurot.2025.e00719_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.pbr.2019.10.002","article-title":"Focusing on cellular biomarkers: the endo-lysosomal pathway in Down syndrome","volume":"251","author":"Bott\u00e9","year":"2020","journal-title":"Prog Brain Res"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00719_bib28","doi-asserted-by":"crossref","first-page":"e1465","DOI":"10.1542\/peds.2006-3448","article-title":"Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development","volume":"120","author":"Whittle","year":"2007","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00719_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00702-007-0656-1","article-title":"Plasma amino acids and neopterin in healthy persons with Down's syndrome","volume":"114","author":"Coppus","year":"2007","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67195-z","article-title":"Plasma metabolome and cognitive skills in Down syndrome","volume":"10","author":"Antonaros","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2025.e00719_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105316","article-title":"Neurometabolite mapping highlights elevated myo-inositol profiles within the developing brain in Down syndrome","volume":"153","author":"Patkee","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00719_bib32","first-page":"79","article-title":"Reactive oxygen metabolites and prooxidant status in children with Down's syndrome","volume":"21","author":"Carratelli","year":"2001","journal-title":"Int J Clin Pharmacol Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib33","article-title":"Cobinamide is a strong and versatile antioxidant that overcomes oxidative stress in cells, flies, and diabetic mice","volume":"1","author":"Chang","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.neurot.2025.e00719_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.pa.24.040184.002315","article-title":"Cyanide intoxication and its mechanism of antagonism","volume":"24","author":"Way","year":"1984","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00719_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0041-008X(86)90251-6","article-title":"Cyanide-induced neurotoxicity: role of neuronal calcium","volume":"84","author":"Johnson","year":"1986","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00719_bib36","series-title":"Clinical and experimental toxicology of cyanides","first-page":"41","article-title":"Toxicology of cyanides","author":"Ballantyne","year":"1987"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1995.1163","article-title":"Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases","volume":"134","author":"Dawson","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00719_bib38","series-title":"Toxicological profile for cyanide","year":"2006"},{"key":"10.1016\/j.neurot.2025.e00719_bib39","series-title":"Toxicology of cyanides and cyanogens: experimental, applied and clinical aspects","first-page":"209","article-title":"Cyanide-induced neural dysfunction and neurodegeneration","author":"Isom","year":"2015"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11011-011-9237-y","article-title":"Neurological disorders associated with cassava diet: a review of putative etiological mechanisms","volume":"26","author":"Adamolekun","year":"2011","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00719_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193261","article-title":"Dietary cyanogen exposure and early child neurodevelopment: an observational study from the Democratic Republic of Congo","volume":"13","author":"Kashala-Abotnes","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00719_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/clinchem\/31.4.591","article-title":"Determination of cyanide in whole blood, erythrocytes, and plasma","volume":"31","author":"Lundquist","year":"1985","journal-title":"Clin Chem"},{"issue":"2\u20133","key":"10.1016\/j.neurot.2025.e00719_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/15563658508990623","article-title":"Plasma free cyanide and blood total cyanide: a rapid completely automated microdistillation assay","volume":"23","author":"Groff","year":"1985","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00719_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1570-0232(02)00067-3","article-title":"Rapid quantitation of cyanide in whole blood by automated headspace gas chromatography","volume":"772","author":"Calafat","year":"2002","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00719_bib45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1373\/clinchem.2005.061002","article-title":"Determination of cyanide in blood by isotope-dilution gas chromatography-mass spectrometry","volume":"52","author":"Murphy","year":"2006","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00719_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jcp.23.2.190","article-title":"Rapid cyanmethaemoglobin estimation","volume":"23","author":"Munkley","year":"1970","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00719_bib47","first-page":"409","article-title":"The conversion of haemoglobin to cyanmethaemoglobin","volume":"28","author":"Curran","year":"1971","journal-title":"Med Lab Technol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00719_bib48","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/clinchem\/33.7.1228","article-title":"Cyanide concentrations in blood after cigarette smoking, as determined by a sensitive fluorimetric method","volume":"33","author":"Lundquist","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/j.neurot.2025.e00719_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.aca.2016.12.039","article-title":"The analysis of cyanide in biological samples: a review of past methods and future directions","volume":"960","author":"Jackson","year":"2017","journal-title":"Anal Chim Acta"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00719_bib50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/1354750X.2012.709880","article-title":"Comparison of cyanide exposure markers in the biofluids of smokers and non-smokers","volume":"17","author":"Vinnakota","year":"2012","journal-title":"Biomarkers"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00719_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jat\/bks017","article-title":"The analysis of protein-bound thiocyanate in plasma of smokers and non-smokers as a marker of cyanide exposure","volume":"36","author":"Youso","year":"2012","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.neurot.2025.e00719_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109289","article-title":"Mental retardation in Down syndrome: two ways to treat","volume":"131","author":"Kamoun","year":"2019","journal-title":"Med Hypotheses"},{"issue":"45","key":"10.1016\/j.neurot.2025.e00719_bib53","doi-asserted-by":"crossref","first-page":"30901","DOI":"10.1074\/jbc.M114.602664","article-title":"Organization of the human mitochondrial hydrogen sulfide oxidation pathway","volume":"289","author":"Libiad","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00719_bib54","first-page":"1277","article-title":"Mercaptopyruvate sulfurtransferase as a defense against cyanide toxication: molecular properties and mode of detoxification","volume":"14","author":"Nagahara","year":"1999","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00719_bib55","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/biom10040653","article-title":"Role of 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation and cellular bioenergetics in human Down syndrome fibroblasts","volume":"10","author":"Panagaki","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00719_bib56","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1007\/s11357-024-01146-8","article-title":"Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine beta-synthase, H2S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy","volume":"46","author":"Panagaki","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.neurot.2025.e00719_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.niox.2022.07.007","article-title":"Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: structure-activity relationship and mechanism of action","volume":"128","author":"Zuhra","year":"2022","journal-title":"Nitric Oxide"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00719_bib58","article-title":"Oxidation of hydrogen sulfide to polysulfide and thiosulfate by a carbon nanozyme: therapeutic implications with an emphasis on Down syndrome","volume":"36","author":"Derry","year":"2024","journal-title":"Adv Mater"},{"issue":"52","key":"10.1016\/j.neurot.2025.e00719_bib59","doi-asserted-by":"crossref","first-page":"22090","DOI":"10.1073\/pnas.0904082106","article-title":"Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation","volume":"106","author":"Collman","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2025.e00719_bib60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fphys.2015.00210","article-title":"Three toxic gases meet in the mitochondria","volume":"6","author":"Decr\u00e9au","year":"2015","journal-title":"Front Physiol"},{"issue":"Suppl 2","key":"10.1016\/j.neurot.2025.e00719_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nep.14369","article-title":"Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy: an update of current clinical trials","volume":"29","author":"Chen","year":"2024","journal-title":"Nephrology"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00719_bib62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy\u2014implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00719_bib63","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00406-023-01576-z","article-title":"Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia","volume":"273","author":"Rosenbrock","year":"2023","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00719_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.12740\/PP\/OnlineFirst\/126661","article-title":"Glycine transporters in schizophrenia: a new hope or informational noise?","volume":"56","author":"Zakowicz","year":"2022","journal-title":"Psychiatr Pol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00719_bib65","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/nutrit\/nuad091","article-title":"A comprehensive review and meta-regression analysis of randomized controlled trials examining the impact of vitamin B12 supplementation on homocysteine levels","volume":"82","author":"Sohouli","year":"2024","journal-title":"Nutr Rev"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00719_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ncp.11095","article-title":"Treatment of refractory shock with vitamin B12: a narrative review","volume":"39","author":"Wedemire","year":"2024","journal-title":"Nutr Clin Pract"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00719_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/occmed\/48.7.427","article-title":"Cyanide poisoning: pathophysiology and treatment recommendations","volume":"48","author":"Beasley","year":"1998","journal-title":"Occup Med (Lond)"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00719_bib68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/15563650.2016.1186804","article-title":"The efficacy and adverse effects of dicobalt edetate in cyanide poisoning","volume":"54","author":"Marrs","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00719_bib69","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5662\/wjm.v5.i2.88","article-title":"Past, present and future of cyanide antagonism research: from the early remedies to the current therapies","volume":"5","author":"Petrikovics","year":"2015","journal-title":"World J Methodol"}],"updated-by":[{"DOI":"10.1016\/j.neurot.2026.e01116","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000}}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:45:17Z","timestamp":1772894717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925001977"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00719","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyanide overproduction impairs cellular bioenergetics in Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00719"}}